TGen News & Press Releases

COMBAT study preliminary results show response of 32% in treatment of pancreatic tumors

Posted Tuesday August 11, 2020

TGen and HonorHealth investigators are encouraged with results and hope to show patient benefit in larger studies

25-year dolphin study reveals factors contributing to aging rates in long-lived mammals

Posted Monday August 10, 2020

TGen-Epitracker analysis of U.S. Navy data uncovers groundbreaking science that may help delay aging in dolphins and humans

UArizona-TGen led team identifies new biomarkers to diagnose and monitor brain injuries

Posted Friday July 31, 2020

Integrated protein and metabolite analysis open the door to more precise ways of guiding treatment for the nearly 70 million people worldwide who annually suffer traumatic brain injuries

TGen Center for Rare Childhood Disorders patient is headed to Mars

Posted Thursday July 23, 2020

Alex Yiu, whose rare neurological disorder was diagnosed by TGen, will celebrate a combination birthday and ‘Perseverance’ pre-launch party and fundraiser on July 25

Ashion Analytics announces innovative cancer treatment partnership with Elevation Oncology

Posted Wednesday July 22, 2020

Ashison Analytics GEMExTra test detects rare NRG1 gene fusions in patients whose cancer is driven by this genomic alteration for potential matching to a clinical trial

TGen, City of Hope looking to create personalized roadmaps for the treatment of kidney cancer

Posted Wednesday July 22, 2020

Physician-scientists are using one of the world’s most comprehensive genomic analysis tools to determine whether targeted therapy or immunotherapy has the best chance of working for each individual patient

Ashion Analytics receives Medicare coverage for GEM ExTra® assay for patients with advanced solid tumors